MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Fri, Nov 17, 2023
Nov 17
reported an acquisition in ALKS
1,089 shares @ $65.94
Increased holdings by +2.00%
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.76%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback